Fig. 3

Planar scintigraphy (anterior and posterior views) after therapeutic application of [177Lu]Lu-DOTAZOL at a 20 min, b 3 h, c 24 h, and d 168 h in a patient with bone metastases secondary to prostate cancer (patient no. 1)
Planar scintigraphy (anterior and posterior views) after therapeutic application of [177Lu]Lu-DOTAZOL at a 20 min, b 3 h, c 24 h, and d 168 h in a patient with bone metastases secondary to prostate cancer (patient no. 1)